Meet In CommonNewsRSS feeds

Local

Akeso Announces NMPA Acceptance of sNDA for Ivonescimab in Combination with Chemotherapy for First-Line Biliary Tract Cancer

Meet in Common connects news with real conversations. Use ThinkMatch to arrange a Roundtable and meet people to discuss this story.

Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.

Source: Newnan Times-Herald

HONG KONG, Nov. 16, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the National Medical Products Administration (NMPA) of China has accepted the supplemental New Drug Application (sNDA) for ivonescimab in combination with chemotherapy for the…

This excerpt comes from the named source. Read the original for the full reporting.

Read the original at Newnan Times-Herald

Featured places to meet in Palo Alto, CA

Explore these places and arrange a conversation through ThinkMatch.

City guide for Palo Alto, CA

Community Poll

Schools should be judged on student wellbeing as well as academic results.

Share your view, then see how readers voted. No sign-in required. This poll is shared across stories.

Do you agree or disagree?

Choose one answer

Common Quandary

A Common Quandary to discuss

Another conversation to explore, separate from this news story.

The mayor is excellent at the job—and secretly cheating on a spouse. Is that news?

A local official is effective, honest in office, and privately having an affair. A journalist can verify it but finds no misuse of public resources or direct connection to official duties.

Does private dishonesty reveal something citizens are entitled to judge?

Explore this quandary